Related Experiment Video
Updated: Aug 12, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Myotonic dystrophy--a multigene disorder
1Department of Genetics, Queens Medical Centre, University of Nottingham, Nottingham, UK.
Brain Research Bulletin
|November 24, 2001
Summary
Myotonic dystrophy (DM1) is a common adult muscular dystrophy caused by expanded CTG repeats in the DMPK gene. This mutation leads to gene silencing and toxic gain of function, explaining the disease's varied symptoms.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Myotonic dystrophy (DM1) is the most prevalent adult-onset muscular dystrophy.
- It affects approximately 1 in 8000 births.
- The genetic hallmark is an expanded CTG repeat in the 3' untranslated region of the DMPK gene.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying Myotonic dystrophy (DM1).
- To explain the diverse clinical manifestations of DM1.
- To understand the role of the expanded CTG repeat in DMPK gene regulation.
Main Methods:
- Analysis of the DMPK gene and its 3' untranslated region.
- Investigation of nucleosome positioning and its effect on gene expression.
- Study of transcript retention and nuclear factor sequestration.
Main Results:
- Expanded CTG repeats create strong nucleosome positioning signals, reducing DMPK gene expression.
- DMPK transcripts containing the expansion are retained in the nucleus.
- This retention leads to a toxic gain of function and sequestration of nuclear factors.
Conclusions:
- The molecular pathology of DM1 involves both gene silencing and toxic gain of function.
- These mechanisms, driven by the expanded CTG repeat, explain the complex phenotype of DM1 patients.
- Understanding these processes is crucial for developing targeted therapies.
Related Concept Videos
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:43Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...